Hyperpigmentation ingredients compared

Quick answer

There is no universal “best pigmentation ingredient.” Azelaic acid has relevant pharmacological and melasma evidence; niacinamide has modest cosmetic trial support; topical vitamin C is highly formula-dependent; and topical tranexamic acid has emerging, heterogeneous melasma evidence.

Different strategies—not awards
Strategy	What research has examined	Main limitation
Azelaic acid	Acne, rosacea and melasma contexts depending on product and market	Can sting or irritate; product classification and strength vary
Niacinamide	Appearance of facial spots and melanosome-transfer mechanisms	Small or formula-specific trials do not prove every serum or percentage
L-ascorbic acid	Melasma, photodamage and antioxidant formula contexts	Stability, packaging, pH and tolerability strongly affect the product
Topical tranexamic acid	Mostly melasma studies across varied formulations and combinations	Evidence is heterogeneous; topical use must not be confused with oral treatment

Start with the condition, not the ingredient trend

PIH and melasma studies are not interchangeable. The 2024 PIH systematic review found no uniformly robust solution across the diverse interventions studied in skin of colour. ^{PIH review} A separate melasma meta-analysis found several topical categories with evidence, but results still came from different formulas, comparators and treatment plans. ^{Melasma review}

Formula quality changes the meaning of the label

“Vitamin C” may refer to L-ascorbic acid or a derivative, and the finished product's stability matters. The dedicated systematic review found a limited clinical evidence base despite widespread marketing. ^{Vitamin C review}

Tranexamic acid requires an even firmer route distinction. Trials include oral, injected and topical use; those routes do not share the same risk profile or evidence. The 2024 review also reported considerable heterogeneity. ^{TXA review} Layer & Strand treats oral tranexamic acid as a medical discussion, not a routine-building option.

Stacking does not add evidence

Selecting four individually plausible ingredients does not prove the combination is more effective. It does increase the number of possible irritants and makes it harder to identify the cause of a reaction. Begin with the most relevant, tolerable step and keep photoprotection and trigger control in place.

What we could not verify

An INCI name cannot reveal concentration, delivery, stability, pH, clinical equivalence or personal tolerance. We also cannot transfer a study result to an untested retail formula simply because it contains the same headline active.

Bottom line

Compare pigment ingredients by the problem studied, quality of the finished formula and irritation cost. A shorter routine with a clear purpose is more informative than an untested stack of popular actives.

Hyperpigmentation ingredients compared: roles, evidence and limits

Start with the condition, not the ingredient trend

Formula quality changes the meaning of the label

Stacking does not add evidence

Sources